Skip to content

Dose Effects of SCF on Calcium Metabolism and GI Microflora in Adolescents

Dose Response Effects of Soluble Corn Fiber (SCF) on Calcium Metabolism and Gastrointestinal Microflora in Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01660503
Enrollment
30
Registered
2012-08-08
Start date
2012-06-01
Completion date
2014-04-30
Last updated
2018-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Keywords

Calcium absorption, Osteoporosis, Bone Health, Adolescent

Brief summary

Soluble corn fiber (SCF) has been shown to enhance calcium utilization and bone properties in rats and in adolescent boys and girls.

Detailed description

The growing knowledge of non-digestible oligosaccharide (NDO)-related health benefits has led to the identification of other fermentable carbohydrates which may improve bone balance and bone health parameters. One such carbohydrate is the corn derivative, soluble corn fiber (SCF). Already known for its association with improved intestinal health and influence on colonic microflora content, we have been studying the effects of SCF on calcium absorption and bone health. First we found that soluble corn fiber (SCF) greatly enhanced calcium utilization and bone properties in a growing rat model. Results from this study demonstrated that SCF was capable of increasing bone mineral content, density and bone strength parameters in 4-week old, male rats. Our study in adolescent boys and girls showed a 12% increase in calcium absorption after consuming 12 g SCF for 21 days compared to a control period in a crossover design using a controlled feeding metabolic balance approach. Given these profound changes on calcium absorption and in bone, a logical next step is to study a dose-response effect of SCF on calcium absorption, bone turnover, and gut microflora in free-living adolescents.

Interventions

DIETARY_SUPPLEMENT0 grams SCF

Given in snack foods (muffins and flavored beverage)

DIETARY_SUPPLEMENT10 grams SCF

Given in snack foods (muffins and flavored beverage)

DIETARY_SUPPLEMENT20 grams SCF

Given in snack foods (muffins and flavored beverage)

Sponsors

Tate and Lyle Ingredients Americas LLC
CollaboratorUNKNOWN
Purdue University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
9 Years to 13 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adolescent Caucasian girls between the ages of 12-14. This population has been chosen because they exhibit higher risk for osteoporosis later in life.

Exclusion criteria

* Habitual dietary patterns including less than 550 and greater than 1500 mg Ca per day. This represents the 5th and 95th percentile of usual intake of girls 9-13 y in the US. * History of smoking, alcohol use, illegal or non-prescription drug use * History of disordered calcium or bone metabolism e.g. Paget's disease, hyper or hypo-calcemia * History of gastrointestinal diseases (Crohn's, celiac, inflammatory bowel disease) * History of diseases that affect kidney or liver function. * Body Mass Index (BMI) less than 5th percentile for age or greater than the 90th percentile for age * Having a broken bone within the last 6 months. * Regular consumption of foods or supplements containing prebiotics or probiotics * History of pregnancy or use of contraceptives

Design outcomes

Primary

MeasureTime frameDescription
Calcium Absorption4 WeeksThe subject will be asked to consume one snack item in the morning and one snack in the evening for four consecutive weeks. After consuming the SCF product for four weeks the teen will come to Purdue University campus for 3 nights and days (e.g. Thursday noon - Sunday noon). They will reside in university residence hall or hotel near campus. Calcium Absorption testing will be done utilizing 43Ca and 44Ca.

Secondary

MeasureTime frameDescription
GI microbial changes4 weeksFecal microbial analyses will be performed on a baseline sample collected before each 4 week consumption period to establish basal microbial profiles. Additional analyses will be performed on fecal samples collected during the 3 day clinical visit to compare microbial changes in response to SCF treatments.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026